NDRA ENDRA Life Sciences ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility https://www.businesswire.com/news/h...trating-MRI-like-Accuracy-and-Reproducibility
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for the quarter ended March 31, 2026, and provided a business update. https://www.businesswire.com/news/h...inancial-Results-and-Provides-Business-Update
